Lupin 2024

data and decision making

Pressure builds for less costly biologic development

Pressure builds for less costly biologic development

Biologic drugs have increasingly delivered treatments for cancer and rare diseases and continue to prove effective in other wide-ranging areas, from neurological and metabolic disorders to respiratory and cardiovascular diseases. But along with the incredible potential biologics offer, there is also great pressure to discover and deliver novel treatments quickly and cost effectively. Biologics represent

The role of artificial intelligence in drug discovery

The role of artificial intelligence in drug discovery

Despite the buzz around artificial intelligence (AI), most industry insiders know that the use of machine learning (ML) in drug discovery is nothing new. For more than a decade, researchers have used computational techniques for many purposes, such as finding hits, modeling drug-protein interactions and predicting reaction rates. What is new is the hype. As

PP_1170x120_10-25-21